News & Analysis
- Data & Tools
- Login | Register
Scrutiny of biopharma innovators’ coronavirus IP strategies will continue to intensify in coming months as concerns mount about access to treatments
21 May 2020
With Mexico’s change of government, new trends and practices have been introduced, affecting, among other things, the regulatory and IP framework. This chapter contains an overview of the main ammendments made throughout 2019 and a brief discussion on what it is expected for 2020.
07 May 2020
This chapter highlights the strategic questions surrounding patent prosecution, patent litigation and the regulation of biologics and biosimilars on the Brazilian market.
06 May 2020
One of the most common questions regarding patent protection in Brazil refers to whether there is a possibility of protecting second medical use of known chemical compounds. The answer is simple: yes, it is possible to protect second medical use in Brazil.
06 May 2020
Innovators must overcome demanding inventive step and novelty requirements to protect repurposed drugs in Latin America’s largest market
04 May 2020
New capital will help Chicago-based business scale-up as it looks to develop new marketplace, says firm's head Jim Malackowski; possible expansion of international arm into India and Brazil also being considered
24 April 2020
A covid-19 vaccine could be produced by anyone, but only a few major players had been actively strengthening and building their portfolios before the pandemic struck
17 April 2020
WHO to establish voluntary patent pool, while Greek Prime Minister calls for EU to buy rights to vaccines and tests
09 April 2020
A selection of some of the exclusive interviews we have run with the indviduals running the world's most important patent offices
08 April 2020
Several countries have introduced new laws – or have faced calls – to strengthen their ability to bypass patents
07 April 2020
Unlock unlimited access to all IAM content